Introduction
The obesity epidemic, currently affecting more than 35% of the population in the United States, is associated with several deleterious changes in lipid metabolism, including increased serum lipids, and glucose/insulin homeostasis. Hyperlipidemia is a risk factor for cardiovascular disease (CVD) and is estimated to be responsible for more than half of cardiovascular mortality (1) (2) (3) .
The prorenin receptor (PRR) is a component of the renin angiotensin system involved in the regulation of blood pressure and fluid volume. PRR exists in three different forms: a full-length integral transmembrane protein, a soluble PRR (sPRR) and a truncated form composed of a transmembrane and a cytoplasmic domain (4) (5) (6) (7) . Increasing evidence suggests that the function of PRR is not restricted to blood pressure control (8) (9) (10) . PRR can also interact with t -catenin pathway or with the vacuolar-type H-ATPase, two crucial pathways involved in tissue and organ development (8, (11) (12) (13) (14) . Evidence also indicates that both PRR and sPRR play role in obesity, energy and lipid metabolism (15) (16) (17) (18) . Indeed, we previously showed that adipose PRR KO prevented the development of obesity and drastically decreased fat mass (15) . Paradoxically, the deletion of PRR in adipose tissue increased plasma sPRR and induced lipid redistribution in the liver that led to liver steatosis (15) . Moreover, sPRR and PRR was elevated in the liver of adipose PRR KO mice (19) suggesting that the elevation of plasma sPRR likely originated from the liver.
Lu et al., silenced PRR in hepatocytes and found that PRR deletion decreased cellular LDL uptake and reduced SORT1 and LDLR proteins levels (16) . In mice, the knockdown of PRR in liver, using antisense oligonucleotides (ASO), impaired hepatic LDL clearance (17) . However, plasma sPRR levels were not quantified in this study. Thus, the relative contribution of sPRR to lipid homeostasis was not assessed.
Therefore, we first aimed to determine whether the deletion of PRR specifically in hepatocytes influenced plasma sPRR levels in mice fed a standard diet using an adeno-associated viral (AAV)-thyroxine binding globulin (TBG) promoter-Cre recombinase vector administered to PRR "floxed" mice (Liver PRR KO).
Since we found that the deletion of hepatic PRR increased plasma sPRR levels, we next investigated the 
Lipoprotein cholesterol and apolipoprotein distribution.
The cholesterol distribution among lipoprotein classes was determined after separation by gel filtration chromatography based upon the method described previously (20) . An aliquot of plasma was diluted in Page | 5 0.9% NaCl, 0.05% EDTA/NaN3 and centrifuged at 2000 x g for 10 minutes to remove any particulate debris. The supernatant was transferred to a glass insert contained in a GC vial. After loading the vial into an autosampler set at 4°C (G1329A, Agilent Technologies, Santa Clara, CA), 40 μL of sample was injected onto a Superose 6 10/300 or Superose 6 Increase 10/300 (GE Healthcare Life Sciences, Pittsburgh, PA) chromatography column. Under the control of an isocratic pump (G1310A/B, Agilent Technologies, Santa Clara, CA), the sample was separated at a flow rate of 0.4 ml/min with eluent containing 0.9% NaCl, 0.05% EDTA/NaN3. The column effluent was mixed with total cholesterol enzymatic reagent (C7510, Pointe Scientific, Canton, MI) running at a flow rate of 0.125 mL/min and the mixture was passed through a knitted reaction coil (EPOCOD, Aura Industries Inc., San Diego, CA) in a 37°C H2O jacket. The absorbance of the reaction mixture was read at 500 nm using a variable wavelength detector (G1314F, Agilent
Technologies, Santa Clara, CA). The signal was subsequently integrated using Agilent OpenLAB Software Suite (Agilent Technologies, Santa Clara, CA). For apolipoprotein distribution, plasma was separated by gel filtration chromatography as described above and then 3 min fractions were collected between 18 and 48 minutes for further analysis by western blot.
Quantification of liver lipids. Liver lipid content was determined based upon the method described by Carr et al., (21) . A piece of frozen liver was thawed and minced with a razor blade. Following transfer to a tared 16x100mm glass tube, the wet weight of the tissue was measured using an analytical balance. To extract the lipids from the tissue, 3 ml 2:1 chloroform:methanol (CHCl3:MeOH) was added and incubated at 55°C for 2 hours. After centrifuging the tube at 1,500xg for 10 min, the lipid extract was transferred to a new 16x100 mm glass screw top tube. The tube containing the extracted liver was washed with 2 ml 2:1
CHCl3:MeOH and centrifuged as described above. The lipid extract and wash were combined and the solvent was evaporated under nitrogen at 55°C. The dried lipid extract was dissolved in 6 ml of 2:1 CHCl3:MeOH. After the addition of 1.2 ml dilute H2SO4 (0.05%, v/v), the sample was vortexed for 20 seconds and the phases were separated by centrifugation as described above. The upper aqueous phase was removed and an aliquot (typically 1 ml) of the bottom, lipid-containing organic phase was transferred to a new 16x100 mm glass screw top tube using a volumetric glass pipet. After adding 2 ml 1% Trition-X100 Page | 6 dissolved in CHCl3, the organic solvent was evaporated under nitrogen at 55°C. The dried sample was dissolved in 1 ml water and heated at 60°C for 10 min. After vortexing and centrifuging as above, samples dissolved in 2% Triton-X100/water were analyzed for triglycerides using a Wako kit (Wako Chemicals, Richmond, VA). Standards for the triglycerides assay were created using vegetable oil and were dissolved in 2% Triton-X100/water. Organic-solvent resistant, Teflon lined caps were used to seal the tubes throughout the protocol.
Tissue RNA extraction and quantitative RT-PCR. RNA was extracted from liver and EF using the SV 
Results

The deletion of PRR in liver induced hepatomegaly and disturbed lipid homeostasis
Male PRR fl/fl mice treated with AAV-TBG p -Cre (Liver PRR KO) exhibited significantly reduced liver PRR mRNA ( Figure 1A ) and protein levels ( Figure 1B ) compared to mice treated with vehicle (CTL). The body weight of Liver PRR KO mice were not significantly different from CTL mice ( Figure 1C ). The deletion of PRR in liver did not significantly change total fat and lean masses (expressed as percent of body weight, Page | 8 Figure 1D ). Moreover, the weights of the retro-peritoneal fat (RPF), epididymal fat (EF) and subcutaneous fat (subc) were not significantly different in Liver PRR KO mice compared to CTL mice (Table 1) .
Interestingly, liver weights increased significantly in Liver PRR KO compared to CTL mice (Table 1) .
Additionally, the deletion of hepatic PRR increased the levels of plasma total and free cholesterol ( Figure   2A and 2B), and LDL cholesterol ( Figure 2D and 2E) and did not change plasma triglycerides levels ( Figure   2C ). Hepatic LDLR protein levels (non glycosylated form, 95 KDa) decreased significantly in Liver PRR KO mice compared to CTL mice ( Figure 3A and 3B ).
Because we previously showed that the deletion of PRR in adipose tissue down-regulated and consequently prevents triglyceride accumulation in the lipid droplets of adipocytes; we aimed to determine whether hepatic PRR deletion influenced and triglycerides contents in the liver. Indeed, protein levels (glycosylated form, 75 KDa) and hepatic triglycerides levels decreased significantly in the liver of Liver PRR KO mice compared to CTL mice ( Figure 3A, 3B and 3C ).
Hepatic proinflammatory effectors TNF--1 mRNA levels increased significantly in Liver PRR KO mice compared to CTL mice ( Figure 3D ).
The deletion of hepatic PRR elevated hepatic cholesterol likely through an up-regulation of SREBP2 and HMG CoA-reductase
The deletion of PRR in liver induced a significant increase in total cholesterol content in the liver of Liver PRR KO mice compared to CTL mice ( Figure 4A , P<0.05). Furthermore, genes involved in cholesterol synthesis, especially SREBP2 and HMG CoA-reductase (HMG CoA-R), were significantly upregulated in the liver of Liver PRR KO mice compared to CTL mice ( Figure 4B , P<0.05). Together our data suggested that hepatic PRR is an important regulator of endogenous cholesterol synthesis.
The deletion of hepatic PRR increased circulating sPRR, which could promote the up-regulation of hepatic SREBP2
Interestingly, Liver PRR KO mice exhibited elevated plasma sPRR levels compared to CTL mice vehicle ( Figure 4C ) raising the question of the relative contribution of PRR and sPRR to endogenous cholesterol synthesis. Therefore, to determine whether sPRR was involved in cholesterol synthesis, HepG2 cells were transfected with siPRR and treated with or without a mouse recombinant sPRR-His-Tag (Figure 4) . PRR expression increased significantly in HepG2 cells treated with sPRR compared to HepG2 cells treated with vehicle, suggesting an autoregulatory loop in which sPRR upregulated its own gene expression ( Figure   4D ). The silencing of PRR in HepG2 cells did not change SREBP2 mRNA levels. However, sPRR treatment induced a significant increase of SREBP2 expression suggesting that sPRR mediated SREBP2 upregulation independently of PRR expression ( Figure 4E ).
PRR and sPRR programed adipose tissue fate through up-regulation of genes involved in adipogenesis and fat mobilization
Since sPRR plasma levels doubled in Liver PRR KO mice, we next investigated the origin of this increase.
Interestingly, total sPRR levels were significantly higher in the EF of Liver PRR KO mice than in CTL mice ( Figure 5A ) suggesting that the deletion of hepatic PRR induced a compensatory increase of plasma sPRR partially or fully originating from adipose tissue. Since we previously demonstrated that deleting PRR in adipose tissue lowers expression of genes involved in adipogenesis, lipid synthesis and trafficking (15, 19) , we assessed the adipogenesis status of the adipose tissue of Liver PRR KO mice. Interestingly, the deletion of hepatic PRR led to increased PRR expression ( Figure 5B ) and elevated the level of PRR protein in adipose tissue ( Figure 5C ). In line with this increase, , FABP4 and ATGL gene expressions increased significantly in the EF of Liver PRR KO mice compared to CTL mice ( Figure 5B ).
Additionally, protein levels were higher in the EF of Liver PRR KO mice compared to CTL mice ( Figure 5C ). Together our data demonstrated that the deletion of liver PRR initiated the cascade regulation of adipocyte differentiation Page | 10
To confirm the relative contribution of sPRR to the regulation of expression, 3T3-L1 cells were treated with and without mouse recombinant sPRR-His-Tag. Our results demonstrated a dose response gene expression suggesting that sPRR might influence adipocyte differentiation by stimulating and PRR gene expression in an autocrine manner ( Figure 6A and 6B) .
Discussion
Our study demonstrated that sPRR and hepatic PRR contribute to lipid homeostasis. To our knowledge, no prior studies examined the role of sPRR in lipid homeostasis. Deleting hepatic PRR induced an increase of hepatic cholesterol, an up-regulation of SREBP2 and HMG CoA-R but also elevated circulating sPRR.
Therefore, we investigated whether the stimulation of cholesterol synthesis was attributed to a lack of hepatic PRR or due to elevated levels of plasma sPRR. In vitro studies demonstrated that sPRR treatment up-regulated SREBP2 gene expression independently of PRR suggesting that circulating sPRR could contribute to hepatic cholesterol biosynthesis. Moreover, deleting hepatic PRR elevated total sPRR proteins levels in epididymal fat indicating that the increase of circulating sPRR likely originated from adipose tissue. Finally, we demonstrated that sPRR could participate in adipocyte differentiation through a PRR/PPAR dependent mechanism.
The present study is in agreement with previous reports showing an association between PRR and lipoprotein metabolism (16, 17) . Indeed, the silencing of PRR in HEK293, A431 and HepG2 cells impaired LDL uptake by decreasing SORT1 protein abundance, a regulator of lipid metabolism, and by reducing LDLR abundance (16) . Moreover, the inhibition of hepatic PRR with a N-acetylgalactosamine (P)RR antisense oligonucleotide (ASO-PRR) reduced hepatic LDLR protein levels inducing an elevation of plasma cholesterol in mice fed a normal diet (17) . Additionally, the deletion of hepatic PRR resulted in a cholesterol enrichment of LDL particles (17) . In contrast, we found that hepatic cholesterol levels increased in Liver PRR KO mice whereas hepatic cholesterol levels were unchanged in ASO-PRR mice fed a normal diet. The discrepancy between the results could be attributed to the difference between the two mouse Page | 11 models used, ASO-PRR mice and Liver PRR KO. It is possible that the use of antisense oligonucleotides could have affected nontargeted RNAs or influenced the expression of PRR in other tissues of ASO-PRR mice (22, 23) . We previously showed that the deletion of adipocyte PRR reduced adipose tissue mass through a downregulation of PPAR gene expression and reduced genes involved in lipid transport and synthesis (15, 19) . In ASO-PRR mice, PRR protein tended to decrease in the adipose tissue and the fat mass was reduced in high fat-fed ASO-PRR mice suggesting that adipogenesis might have been compromised (17) . Additionally, circulating sPRR was not quantified in ASO-PRR mice and therefore the relative contribution of sPRR to the phenotype not investigated.
We previously demonstrated that the increased plasma sPRR in SD-or HF-fed adipose-PRR KO mice originated from the liver (15, 19) . In the present study, we demonstrated that the increased plasma sPRR levels likely originated from the adipose tissue in liver PRR KO mice. Together, our studies suggest that a compensatory mechanism occurs between the liver and the adipose to counteract the lack of a functional tissue PRR. Hence, a liver-adipose tissue cross talk is essential for PRR regulation. In the present study, we showed that sPRR up-regulated PRR gene expression in Hep-G2 cells. This finding is consistent with our recent report showing an increase of hepatic PRR gene expression in female mice infused with sPRR (19) .
Interestingly, sPRR treatment cannot rescue the expression of its own gene in siPRR treated cells, suggesting that the positive feedback loop is PRR-dependent.
SREBP-2 is an essential transcription factor for de novo cholesterol synthesis, notably through its positive regulation of HMG-CoA reductase gene expression (24) (25) (26) . In our study, elevated hepatic cholesterol is associated with an upregulation of SREBP-2 and HMG-CoA reductase gene expression suggesting a stimulation of cholesterol synthesis. Since circulating sPRR was elevated in Liver PRR KO, we investigated the relative contribution of PRR and sPRR to SREBP-2 regulation. sPRR treatment elevated SREBP-2 gene expression while PRR silencing had no effect on SREBP-2 transcripts, suggesting that sPRR participated in SREBP-2 regulation independently of PRR. Therefore, sPRR might be a new contributor to hepatic lipid metabolism potentially by initiating endogenous cholesterol synthesis via SREBP-2.
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PRR is expressed abundantly in adipose tissue and accumulating evidences demonstrates that PRR is a master regulator of adipogenesis. In addition, the development of obesity induces an increase of PRR gene expression in adipose tissue of mice, rats, and human (15, 27, 28) . Treatment with the handle region peptide, a PRR blockade, reduced fat mass and adipocyte size, as well as leptin and inflammatory cytokines levels (29). Furthermore, the silencing of PRR in 3T3- (15) . In line with previous works, the present study indicated that FABP4 and perilipin gene expression in 3T3-L1 cells in a dose dependent manner. Thus, sPRR could stimulate adipogenesis through a PRRdependent mechanism. However, this stimulation does not seem enough to change the fat mass in mice fed a standard diet and a second hit (such as high fat diet) might be required to trigger this effect.
Similar to the study of Ren et al., (17) , hepatic triglyceride levels and expression were reduced in liver PRR KO mice. Previous report demonstrated that te was associated with a decrease in hepatic triglycerides (30) . Additionally, in the reduction of liver triglycerides was attributed to an increase in triglycerides clearance (31) . Since we showed that plasma triglycerides was not changed in liver PRR KO mice and since Ren et.al., showed a reduced hepatic triglycerides in high-fat fed ASO PRR KO, one could speculate that down-regulation of hepatic influenced not only liver triglyceride clearance but also liver triglyceride synthesis (32) .
In conclusion, we demonstrated that PRR and sPRR contributed to lipid homeostasis by stimulating regulatory pathways involved in LDLR clearance, cholesterol synthesis and adipocyte differentiation. Data are mean±SEM of a total of 12 replicates from 3 experiments. r, Pearson correlation coefficient.
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